Cyclacel Pharma (CYCC) Misses Q4 EPS by 45c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Total other income (expense): 77K
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Total other income (expense): 77K
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($1.18), $0.45 worse than the analyst estimate of ($0.73). Revenue for the quarter came in at $277 thousand versus the consensus estimate of $210 thousand.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Helius Medical Technologies (HSDT) Misses Q2 EPS by 31c
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
